drugset / Trial / NCT06550089

High Or Low Dose pOstpartUm Oxytocin at the Time of Cesarean Birth

NCT06550089 ↗

RandomizedParallel-groupOpen-labelPrevention

Summary

This is a study to investigate whether it is feasible to conduct a randomized controlled trial (RCT) of a high dose of oxytocin versus the standard low-dose oxytocin. Further the investigators, aim to assess whether there are differences in health outcomes between both arms of the study.

Timeline

Start
2024-10
Primary completion
2026-10
Completion
2026-12

Outcome

Outcome not reported

Stopped: “Study will be restarted at a later date”

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 18 iu Intravenous
Subject Oxytocin Peptide 36 iu Intravenous
Subject Oxytocin Peptide 54 iu Intravenous

Indications